| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13864* | 2021 |
| Non-motor symptoms of Parkinson's disease: diagnosis and management KR Chaudhuri, DG Healy, AHV Schapira The Lancet Neurology 5 (3), 235-245, 2006 | 3697 | 2006 |
| Mitochondrial complex I deficiency in Parkinson's disease AHV Schapira, JM Cooper, D Dexter, JB Clark, P Jenner, CD Marsden Journal of neurochemistry 54 (3), 823-827, 1990 | 2638 | 1990 |
| Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment KR Chaudhuri, AHV Schapira The Lancet Neurology 8 (5), 464-474, 2009 | 2248 | 2009 |
| Non-motor features of Parkinson disease AHV Schapira, KR Chaudhuri, P Jenner Nature Reviews Neuroscience 18 (7), 435-450, 2017 | 2176 | 2017 |
| Mitochondrial complex I defi ciency in Parkinson’s disease AHV Schapira, JM Cooper, D Dexter, P Jenner, JB Clark, CD Marsden LANCET 1, 1269-1269, 1989 | 1812 | 1989 |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008 | 1749 | 2008 |
| The chemistry of contrast agents in medical magnetic resonance imaging AS Merbach, L Helm, É Tóth John Wiley & Sons, 2013 | 1746 | 2013 |
| Parkinson disease R Balestrino, AHV Schapira European journal of neurology 27 (1), 27-42, 2020 | 1624 | 2020 |
| Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases MWJ Cleeter, JM Cooper, VM Darley-Usmar, S Moncada, AHV Schapira FEBS letters 345 (1), 50-54, 1994 | 1603 | 1994 |
| Mitochondrial disease AHV Schapira The Lancet 368 (9529), 70-82, 2006 | 1430 | 2006 |
| International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study KR Chaudhuri, P Martinez‐Martin, AHV Schapira, F Stocchi, K Sethi, ... Movement disorders: official journal of the Movement Disorder Society 21 (7 …, 2006 | 1361 | 2006 |
| The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: results from an international pilot study KR Chaudhuri, P Martinez‐Martin, RG Brown, K Sethi, F Stocchi, P Odin, ... Movement disorders 22 (13), 1901-1911, 2007 | 1208 | 2007 |
| Mitochondria in the aetiology and pathogenesis of Parkinson's disease AHV Schapira The Lancet Neurology 7 (1), 97-109, 2008 | 1091 | 2008 |
| Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy ME Gegg, JM Cooper, KY Chau, M Rojo, AHV Schapira, JW Taanman Human molecular genetics 19 (24), 4861-4870, 2010 | 1083 | 2010 |
| Missing pieces in the Parkinson's disease puzzle JA Obeso, MC Rodriguez-Oroz, CG Goetz, C Marin, JH Kordower, ... Nature medicine 16 (6), 653-661, 2010 | 1016 | 2010 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 972 | 2017 |
| Mitochondrial defect in Huntington's disease caudate nucleus M Gu, MT Gash, VM Mann, F Javoy‐Agid, JM Cooper, AHV Schapira Annals of Neurology: Official Journal of the American Neurological …, 1996 | 925 | 1996 |
| Etiology and pathogenesis of Parkinson's disease AH Schapira, P Jenner Movement disorders 26 (6), 1049-1055, 2011 | 896 | 2011 |
| Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ... Neurobiology of disease 42 (3), 360-367, 2011 | 855 | 2011 |
